Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

DEAN C DIMMITT

Allopathic & Osteopathic Physicians Internal Medicine

NPI
1447334800
CMS profile
19949
Location
DALLAS, TX

General Payments · PY2018–2024

$4,073.57

  • Reported across 210 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$736.44

36 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $736.44 36

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Abbott Laboratories $246.90 11
Novo Nordisk AS $148.96 10
Cleerly, Inc. $81.09 2
Amgen Inc. $62.38 3
GlaxoSmithKline, LLC. $50.84 3
Boehringer Ingelheim Pharmaceuticals, Inc. $50.30 2
Sumitomo Pharma America, Inc. $25.06 1
PFIZER INC. $20.85 1
SANOFI-AVENTIS U.S. LLC $19.41 1
ABBVIE INC. $16.74 1
Itamar Medical Inc $13.91 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $1,267.60 76
PY2019 $816.17 41
PY2020 $172.25 11
PY2021 $581.03 30
PY2022 $339.05 8
PY2023 $161.03 8
PY2024 $736.44 36

Payment records · PY2024 (36)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Abbott Laboratories $23.32 01/10/2024 Food and Beverage Undisputed 01/23/2026 1125070255 CMS
Abbott Laboratories $21.01 01/18/2024 Food and Beverage Undisputed 01/23/2026 1125070257 CMS
Abbott Laboratories $23.45 02/27/2024 Food and Beverage Undisputed 01/23/2026 1125070259 CMS
Abbott Laboratories $21.27 03/12/2024 Food and Beverage Undisputed 01/23/2026 1125070261 CMS
Abbott Laboratories $22.23 04/25/2024 Food and Beverage Undisputed 01/23/2026 1125070263 CMS
Abbott Laboratories $22.80 05/01/2024 Food and Beverage Undisputed 01/23/2026 1125070265 CMS
Abbott Laboratories $18.64 05/20/2024 Food and Beverage Undisputed 01/23/2026 1125070267 CMS
Abbott Laboratories $22.46 06/21/2024 Food and Beverage Undisputed 01/23/2026 1125070269 CMS
Abbott Laboratories $22.80 09/11/2024 Food and Beverage Undisputed 01/23/2026 1125070275 CMS
Abbott Laboratories $22.94 10/30/2024 Food and Beverage Undisputed 01/23/2026 1125070271 CMS
Abbott Laboratories $25.98 12/20/2024 Food and Beverage Undisputed 01/23/2026 1125070273 CMS
ABBVIE INC. $16.74 08/21/2024 Food and Beverage Undisputed 01/23/2026 1103643688 CMS
Amgen Inc. $24.56 02/14/2024 Food and Beverage Undisputed 01/23/2026 1117239701 CMS
Amgen Inc. $24.36 10/22/2024 Food and Beverage Undisputed 01/23/2026 1111564103 CMS
Amgen Inc. $13.46 12/11/2024 Food and Beverage Undisputed 01/23/2026 1111564105 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $29.40 08/26/2024 Food and Beverage Undisputed 01/23/2026 1118012649 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $20.90 10/08/2024 Food and Beverage Undisputed 01/23/2026 1118012647 CMS
Cleerly, Inc. $32.83 02/13/2024 Food and Beverage Undisputed 01/23/2026 1144710654 CMS
Cleerly, Inc. $48.26 08/05/2024 Food and Beverage Undisputed 01/23/2026 1144710770 CMS
GlaxoSmithKline, LLC. $17.29 07/31/2024 Food and Beverage Undisputed 01/23/2026 1116315054 CMS
GlaxoSmithKline, LLC. $15.40 10/07/2024 Food and Beverage Undisputed 01/23/2026 1115799353 CMS
GlaxoSmithKline, LLC. $18.15 11/20/2024 Food and Beverage Undisputed 01/23/2026 1116565446 CMS
Itamar Medical Inc $13.91 11/19/2024 Food and Beverage Undisputed 01/23/2026 1151577880 CMS
Novo Nordisk Inc $16.99 01/17/2024 Food and Beverage Undisputed 01/23/2026 1096979395 CMS
Novo Nordisk Inc $4.52 02/15/2024 Food and Beverage Undisputed 01/23/2026 1096941533 CMS
Novo Nordisk Inc $16.09 02/28/2024 Food and Beverage Undisputed 01/23/2026 1097417186 CMS
Novo Nordisk Inc $13.76 05/29/2024 Food and Beverage Undisputed 01/23/2026 1097105755 CMS
Novo Nordisk Inc $21.19 06/26/2024 Food and Beverage Undisputed 01/23/2026 1096670435 CMS
Novo Nordisk Inc $18.31 07/22/2024 Food and Beverage Undisputed 01/23/2026 1096617158 CMS
Novo Nordisk Inc $12.81 08/19/2024 Food and Beverage Undisputed 01/23/2026 1097477378 CMS
Novo Nordisk Inc $13.40 09/16/2024 Food and Beverage Undisputed 01/23/2026 1096919734 CMS
Novo Nordisk Inc $13.87 10/21/2024 Food and Beverage Undisputed 01/23/2026 1097252537 CMS
Novo Nordisk Inc $18.02 10/29/2024 Food and Beverage Undisputed 01/23/2026 1097039516 CMS
PFIZER INC. $20.85 11/26/2024 Food and Beverage Undisputed 01/23/2026 1131147385 CMS
SANOFI-AVENTIS U.S. LLC $19.41 09/13/2024 Food and Beverage Undisputed 01/23/2026 1139568775 CMS
Sumitomo Pharma America, Inc. $25.06 11/11/2024 Food and Beverage Undisputed 01/23/2026 1148845705 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.